🎄 Why Christmas Decorations Can Trigger Symptoms

An explainer for people living with aspergillosis, asthma, ABPA, CPA and bronchiectasis

Many people with aspergillosis notice a sudden increase in sneezing, coughing, wheezing or chest tightness when unpacking Christmas decorations. This is extremely common and usually caused by environmental triggers, not new infection.

✅ What’s on decorations after a year in storage?

When decorations, artificial trees, or boxes have been stored for months, they often collect:

Dust
Fungal spores, including Aspergillus
Dampness or musty smells
Particles from cardboard
Fibres from artificial branches

For people with allergic aspergillosis (ABPA), severe asthma or sensitive airways, this sudden exposure can cause an allergic flare or airway irritation.

🎄 Why this affects aspergillosis patients more

Airways may already be inflamed or mucus-filled, so irritants cause quicker reactions.
People with ABPA or SAFS react strongly to environmental allergens.
People with chronic pulmonary aspergillosis (CPA) or bronchiectasis may have reduced clearance, so spores or dust linger longer in the lungs.

This does not usually indicate infection — it’s most often an irritation flare.

🛡️ How to protect yourself next time

A few simple steps make a big difference:

Wear a mask (FFP2) when opening boxes or shaking dust off.
Take boxes outside, or open near an open window.
Wipe decorations with a damp cloth rather than brushing them.
Rinse or wipe artificial trees, especially branches.
Use sealed plastic containers rather than cardboard for storage.
Avoid shaking items indoors, as this scatters spores.

🌬️ If you’ve already had a flare

Most people settle within hours to a few days. You can try:

Your usual inhalers (especially preventers).
Airway clearance if you normally use it.
Saline nebulisers/inhalers, which can soothe irritated airways.
Rest, fluids, and avoiding further triggers for a short while.

Seek medical advice if symptoms are unusual for you, don’t settle, or you are already unwell.

💬 The key message

Decorations don’t cause new aspergillus infection — but they can release a burst of irritants and spores that your lungs react to. Taking a few precautions can help you enjoy the season without a flare.

by GAtherton

Side effects from Biologic Medication

It’s completely understandable to feel unsure before starting a biologic — especially when you’ve heard different experiences from different people.
Most patients with ABPA or severe Aspergillus-related asthma do very well on biologics. Side effects can happen, but they’re usually mild and settle quickly.

🌟 Most people report very few problems

Patients often say:

The injections are straightforward
They feel the same or better within days or weeks
There’s little or no impact on daily life

🌟 Common, mild side effects

These are the ones we hear most often across omalizumab, benralizumab, dupilumab and tezepelumab:

📌 Injection-site reactions

Redness
Itching
A small tender lump
Bruising
These usually disappear within 24–48 hours.

📌 Mild tiredness

Some people feel slightly “wiped out” after the first few doses.

📌 Headache

Very common with the first injection. Less so afterwards.

📌 Minor joint or muscle aches

A bit like the feeling after a flu jab.

📌 Nasal or sinus changes

Occasional mild dryness or congestion, especially with dupilumab.

🌟 Less common (still mild)

Mild tummy upset
Sore throat
A brief “flu-ish” feeling
Temporary increase in eczema (mainly with dupilumab)
Slight mood dip for a day or two (rare)

🌟 Rare but important

These are very uncommon, and your team will explain what to look out for:

Allergic reaction shortly after an injection
(This is why your first dose is supervised.)
Eye inflammation — mostly linked to dupilumab, usually mild and treatable

Your team will give you clear advice on what to do if anything unusual happens.

🌟 What ABPA patients often notice

People with ABPA frequently describe:
👉 Fewer allergic symptoms
👉 Clearer breathing
👉 Much less mucus
👉 Fewer flare-ups and fewer steroids

But biologics don’t help everyone — which is why the first few months are monitored closely.

🌟 Final reassurance

For many aspergillosis patients, biologics are far easier than long-term steroids or antifungals. Most say the benefits outweigh the side effects — but every person’s experience is individual.

by GAtherton

Could this new gene-therapy technology help aspergillosis patients?

Hunter syndrome stem cell treatment

Not directly now — but potentially yes in the longer term.

The gene therapy in the BBC story works because Hunter syndrome is caused by a single faulty gene. Doctors can take stem cells, insert a missing gene, and put them back into the body — and the body starts producing the enzyme that was missing.

Aspergillosis is different.
It isn’t caused by a single gene error — it’s caused by:

An over-reaction of the immune system in ABPA
Underlying lung damage or structural disease in CPA
A combination of genetics, environment, allergens and fungal exposure
Sometimes problems with mucus clearance

So gene therapy is not close to being used for aspergillosis in the same direct way.

**But here’s why the technology could help in the future**

The breakthrough still matters because it shows what is becoming possible:

1. Fixing immune-pathway problems

Some people with ABPA or severe asthma have genetic variants in pathways such as:

IL-4 / IL-5 / IgE regulation
Mucus clearance
Immune “switch-off” mechanisms

In the future, gene therapy could correct faulty immune pathways so the lungs stop over-reacting to Aspergillus.

2. Improving mucus-clearance biology

A big part of aspergillosis is mucus sticking in the airways. If gene therapy can one day boost the function of cilia or mucus-clearing enzymes, that would be a major benefit.

3. Helping people born with lung-structure problems

Some patients develop aspergillosis because they were born with subtle airway abnormalities or genetic bronchiectasis tendencies. Future gene therapies might stabilise or prevent these problems.

4. Fungal infection + rare-disease overlaps

Some immunodeficiency disorders (e.g., CARD9 deficiency) lead to severe fungal infections. This type of therapy is much closer to helping those patients already — because those are single-gene defects.

Realistic timeline

For ABPA or CPA specifically:

Short term (0–10 years): No direct gene therapy.
Medium term (10–20 years): Possible targeted immune-pathway correction for asthma/ABPA.
Long term (20+ years): Potential lung-repair gene therapies, airway-regeneration therapies, or personalised immune-modifying gene treatments.

So this breakthrough doesn’t change aspergillosis care today — but it shows that the tools are coming that could one day target immune-driven diseases much more precisely.

by GAtherton

**Adrenal Insufficiency & Steroid Tapering:

A Complete Patient Guide**

People taking long-term steroids (prednisolone, methylprednisolone, hydrocortisone, dexamethasone) can develop adrenal insufficiency because their adrenal glands “go to sleep” and stop making cortisol.
During tapering, the body must slowly “wake up” again — and this needs careful monitoring.

This guide explains the symptoms, tests, warning signs, and emergency precautions to keep you safe.

⭐ 1. Why adrenal insufficiency happens

Long-term steroid use suppresses the HPA axis (hypothalamus–pituitary–adrenal system).
When daily steroid doses are reduced, your body must produce more of its own cortisol. This takes time.

If the steroid reduction is too quick, or the body is under stress, low cortisol symptoms appear.

⭐ 2. Symptoms to watch for during steroid tapering

These are early signs that your body may not be keeping up with the reduction.

✔ Early, mild symptoms

Fatigue / sudden exhaustion
Muscle weakness
Dizziness when standing
Nausea or reduced appetite
Flu-like aching
Low mood, anxiety, irritability
Brain fog
Feeling unusually cold
Worsening joint or muscle pain

These often improve if the taper is slowed or paused.

⭐ 3. More serious symptoms of low cortisol

These symptoms suggest steroid levels are too low and the taper needs urgent review:

Vomiting
Persistent dizziness
Very low blood pressure
Severe fatigue (unable to function normally)
Salt cravings
Ongoing nausea preventing eating
Faintness or near-collapse

These require medical advice (same day).

⭐ 4. Emergency symptoms — possible adrenal crisis

Call 999 or go to A&E immediately if you develop:

Severe vomiting or diarrhoea
Collapse or inability to stand
Severe dehydration
Confusion
Sudden severe abdominal or back pain
Pale, clammy skin
Rapid breathing
Loss of consciousness

This is a medical emergency.
Patients normally receive 100 mg hydrocortisone IM/IV, but patients allergic to hydrocortisone require a pre-agreed emergency alternative — your endocrinologist must document this clearly.

⭐ 5. Symptoms that mean you may need a temporary “stress dose” of steroids

Your cortisol requirement increases during physical stress.
If you have adrenal suppression, your body cannot produce this extra cortisol.

You may need a temporary increase in dose if you have:

✔ Illness

Fever
Chest infection
Flu-like illness
COVID
Urinary infection
Gastroenteritis
Diarrhoea
Persistent nausea

✔ Physical stress

Injury
Significant fall
Severe pain
Dental surgery
Medical or surgical procedures

✔ Emotional stress

Bereavement
Panic attacks
Trauma

If vomiting prevents taking steroids → seek emergency help immediately.

⭐ 6. Tests used to monitor adrenal function during tapering

Doctors rely on a combination of symptoms and laboratory tests.

✔ Morning cortisol (8–9 am)

A key test to assess recovery.

Typical interpretation:

> 400–500 nmol/L → likely normal function
150–350 nmol/L → recovering / borderline
< 100 nmol/L → adrenal insufficiency

(Exact thresholds vary.)

✔ ACTH level

Shows whether the pituitary is trying to stimulate the adrenals.

Low ACTH → still suppressed
High ACTH → trying to wake adrenals
Normal ACTH + low cortisol → gland slow to respond

✔ Short Synacthen Test (SST)

Gold standard.
A small ACTH injection tests whether your adrenal glands can produce cortisol.

Used when:

taper reaches low doses
symptoms appear
deciding if steroids can be stopped

✔ Electrolytes (U&Es)

Low cortisol may cause:

Low sodium
High potassium (less common in steroid-induced insufficiency)

✔ Blood pressure monitoring

Low cortisol → low BP, dizziness, faintness.

✔ Glucose levels

Low-normal glucose and shakiness may occur during withdrawal.

✔ Clinical symptom review

Symptoms are sometimes more sensitive than tests.

Doctors track:

fatigue
appetite
dizziness
illness triggers
salt cravings
mental state
recovery after small dose increases

⭐ 7. How tapering decisions are made

Tapering depends on:

how long steroids have been taken
current dose
symptoms
test results
presence of illness
rate at which symptoms develop
allergy restrictions (pred/hydrocortisone allergy requires specialist handling)

General principles (not schedules):

Higher doses can reduce more quickly.
Taper slows dramatically near physiological levels
(~4–6 mg pred-equivalent).
If symptoms appear → pause, slightly increase, or slow taper.
SST is used near the end to confirm recovery.

⭐ 8. When to contact your medical team

Same day advice needed

worsening dizziness
persistent nausea
new vomiting
symptoms appear with each taper step
fainting
new severe fatigue
any infection (urinary, chest, flu)

Urgent / A&E

collapse
severe vomiting/diarrhoea
confusion
severe abdominal pain
unable to take oral steroids
suspected adrenal crisis

⭐ 9. What patients should do to stay safe

Carry a Steroid Emergency Card at all times
Keep emergency instructions from your endocrinologist
Know your Sick Day Rules
Ensure A&E or ambulance crews know about corticosteroid allergy
Keep a written record of tapering plan
Never stop steroids suddenly
Be cautious during illness
Know your emergency steroid plan (alternative if allergic to hydrocortisone)

⭐ Final reassurance

Adrenal insufficiency during tapering is common, manageable, and often reversible.
By monitoring symptoms, using regular blood tests, and following specialist guidance, tapering can be done safely.

You are not alone — your endocrine team will guide every step, especially if allergies (to prednisolone or hydrocortisone) make your case more complex.

With careful observation and a clear emergency plan, serious complications are rare and preventable.

by GAtherton

**Understanding Medicines in Rare Forms of Aspergillosis:

A Complete Guide for Patients with CPA, ABPA, SAFS and Aspergillus Bronchitis**

People living with chronic or allergic forms of aspergillosis often face treatments that fall outside the standard medicine licensing system. You may hear terms like off-label, unlicensed, specials medicines, or rare disease. This guide explains these concepts clearly and safely in a way that helps you feel informed and confident in your care.

⭐ 1. What is a rare disease?

In the UK and EU, a rare disease is defined as:

A condition affecting fewer than 1 in 2,000 people
(≈ fewer than ~33,500 people in the UK)

Although each rare disease affects relatively few people, over 7,000 rare diseases exist, so collectively they affect 1 in 17 people.

⭐ 2. Are CPA, ABPA, SAFS and Aspergillus Bronchitis rare diseases?

Here is how the main Aspergillus-related conditions compare to the rare-disease definition.

Chronic Pulmonary Aspergillosis (CPA)

~3,600 diagnosed UK patients (under-diagnosis likely, but still rare).
✔ CPA is officially recognised as a rare disease.

Allergic Bronchopulmonary Aspergillosis (ABPA)

Occurs in 2.5–5% of all people with asthma.
UK estimate: 125,000–250,000 patients.
✘ ABPA is NOT a rare disease (but it is under-recognised).

Severe Asthma with Fungal Sensitisation (SAFS)

~8,000 estimated UK cases.
✔ SAFS meets the definition of a rare disease.

Aspergillus Bronchitis

Likely <10,000 UK patients.
✔ Aspergillus Bronchitis qualifies as a rare disease.

⭐ Summary Table

Condition	Approx UK Patients	Rare Disease?
CPA	~3,600	✔ YES
ABPA	125,000–250,000	✘ NO
SAFS	~8,000	✔ YES
Aspergillus Bronchitis	<10,000	✔ YES

Understanding whether a condition is rare helps explain why some treatments fall outside standard licensing.

⭐ 3. What is “off-label” prescribing?

Every medicine has a licence describing:

the condition it treats
dose
age group
how long it can be used
route (tablet, injection, inhaler)

Off-label means a doctor uses a licensed medicine in a way not included in the licence.

This can mean:

different disease
different dose
different age group
different route
different duration

Off-label prescribing is safe, legal, common and essential, especially in rare diseases.

⭐ 4. What is an “unlicensed” medicine?

An unlicensed medicine is one that has no UK licence at all.

Examples:

a medicine made specially for one patient (“specials”)
a liquid formulation when only tablets are sold
imported medicines licensed in another country
alternatives for patients with drug allergies

Unlicensed does not mean unsafe — it means the medicine isn’t commercially licensed in the UK.

⭐ 5. Why are off-label and unlicensed medicines common in rare diseases?

Rare diseases like CPA, SAFS and Aspergillus bronchitis:

affect small patient numbers
often have no licensed treatment
rely on specialist expertise and experience
require individualised dosing
cannot wait for slow or expensive licensing processes

Without off-label and unlicensed medicines, many rare-disease patients would have no treatment options.

This is why specialist centres exist.

⭐ 6. Biologics for ABPA: NOT licensed, but safe and widely used

This is a key point for patients.

❗ No biologic is licensed for ABPA

(as of 2025)

Not licensed for ABPA:

Omalizumab (Xolair)
Mepolizumab (Nucala)
Benralizumab (Fasenra)
Dupilumab (Dupixent)

All biologics used in ABPA are therefore off-label.

⭐ Why do specialists use them anyway?

Because evidence is strong that biologics:

reduce ABPA flare-ups
reduce steroid need
improve lung function
improve symptoms
control eosinophilic/IgE-driven inflammation
reduce hospital admissions

ABPA lacks a commercially licensed biologic
→ but specialist evidence supports them strongly.

This is high-quality off-label prescribing.

⭐ 7. How do doctors decide what evidence is “good enough”?

Doctors use several acceptable forms of evidence, including:

✔ Randomised controlled trials

✔ National/international guidelines

✔ NAC / BTS / ECCMID / IDSA specialist protocols

✔ Observational studies and real-world evidence

✔ Case series and case reports

✔ Pharmacological reasoning (mechanisms of disease)

✔ MDT (multidisciplinary team) agreement

✔ Expert clinical experience (important in rare diseases)

All of these count as legitimate evidence.

Rare-disease medicine relies on the best available evidence, not only the “highest-level” evidence.

⭐ 8. Who holds responsibility if something goes wrong?

The prescriber carries responsibility, even for:

off-label use
unlicensed medicines
imported medicines
specials items

They must:

justify the decision
explain risks and benefits
obtain consent
document
monitor

If they follow guidance, they are fully protected by:

NHS indemnity
GMC standards
Trust governance

Patients are not responsible for adverse outcomes.

⭐ 9. Is this risky for the doctor?

Only if done unsafely.

When the doctor:

✔ follows specialist guidelines
✔ explains the situation
✔ documents their reasoning
✔ uses MDT support
✔ monitors closely

…the risk is minimal and fully protected.

In rare diseases, NOT prescribing off-label can be riskier if it denies a patient effective treatment.

⭐ 10. How are patients protected?

Patients with CPA, ABPA, SAFS or Aspergillus bronchitis are protected by:

careful MDT assessment
specialist supervision
decades of centre experience
guideline-supported decisions
regular reviews and monitoring
clear communication and consent
NHS governance systems

Your care is safe, structured and evidence-based.

⭐ Final reassurance for Aspergillosis patients

If you have CPA, ABPA, SAFS or Aspergillus bronchitis:

You are not receiving “experimental” treatment.
Off-label or unlicensed medicines are normal, safe, and essential.
Your specialist team carries the responsibility for these decisions.
Biologics for ABPA are off-label because licensing is slow — not because they are untested.
You are protected by national standards, MDTs, and specialist expertise.
Your treatment is based on the best available evidence, even when the condition is rare.

This is expert, modern care designed to give you the best possible outcome.

by GAtherton

Understanding Mucous Casts in Allergic Bronchopulmonary Aspergillosis (ABPA)

People living with Allergic Bronchopulmonary Aspergillosis (ABPA) often notice thick, unusual mucus coming up during a flare. Some of this mucus can look very different from “normal” sputum and may be described as mucous casts. This leaflet explains what they are, why they happen, and what they mean for your ABPA.

⭐ What are mucous casts?

A mucous cast is a thick, sticky plug of mucus that forms inside your airways.
It takes on the exact shape of the airway or branch it was sitting in – a bit like a soft mould of the inside of your lungs.

When coughed up, casts may look:

long and tube-shaped
soft and rubbery
curled or C-shaped
occasionally branching, like a twig
pale yellow/cream with darker specks

These darker flecks can include dead inflammatory cells, airway debris, and sometimes tiny amounts of fungal material trapped inside.

⭐ Why do they happen in ABPA?

ABPA is not an infection, but an allergic over-reaction to the Aspergillus fungus.
This allergic inflammation causes:

1. Excess mucus production

Your airways create far more mucus than usual.

2. Thicker, stickier mucus

Inflammation changes the chemistry of the mucus, making it harder to clear.

3. Swollen, narrowed airways

This makes it easy for mucus to get stuck and form plugs.

4. Trapped material

Casts can contain:

fungal spores
inflammatory cells
dust or other inhaled particles
old blood or tissue debris

All of this can glue together into a cast.

⭐ Are mucous casts harmful?

They are not dangerous on their own, but they can cause problems:

Airway blockage → breathlessness, wheeze, sudden tightness
Chest infections → trapped mucus is an ideal place for bacteria
ABPA flare-ups → casts often appear during periods of high inflammation
Reduced airflow on CT scans → seen as “bronchial impaction”

Telling your clinical team when you notice casts helps them judge how active your ABPA is.

⭐ What do mucous casts look like in ABPA?

Patients often describe:

“noodles”
“worms”
“rubbery plugs”
“little branches”
“specks of brown/black” within pale mucus

These appearances are normal in ABPA and do not mean your lungs are permanently worsening.

⭐ How are mucous casts managed?

1. Airway clearance

This is the most important step. Techniques include:

huff-coughing
active cycle of breathing
nebulised saline (hypertonic or isotonic)
flutter/PEP devices (Acapella, Aerobika)
chest physiotherapy

These help loosen and move mucus from deeper airways.

2. Medication

Depending on your treatment plan:

inhalers (bronchodilator + inhaled steroids)
biologics (e.g., mepolizumab, dupilumab, omalizumab)
antifungal medication if prescribed as part of your ABPA care
oral steroids if medically appropriate

Biologics can reduce the inflammation that causes casts, so many patients notice fewer plugs over time.

3. Monitoring

Your team may keep an eye on:

sputum samples
IgE levels
CT scan changes
symptom patterns

⭐ When should I tell my team?

Contact your clinical team if you notice:

more frequent mucous casts
sudden breathlessness or chest tightness
a drop in your usual oxygen saturation
fever or signs of infection
coughing up blood
a change in colour or smell of mucus

⭐ Reassurance

Mucous casts are very common in ABPA.
They can look alarming, but they are simply a sign that your airways are inflamed and producing thick mucus.

Coughing them out is helpful, not harmful.
It allows the affected airway to reopen and can rapidly improve breathing.

✅ Further Reading

For more patient-oriented information, you can visit the AFIT website where the term “casts” is discussed in the context of aspergillosis: Aspergillus.org.uk – search “casts”.

by GAtherton

🌿 Your Immune System, Biologics, and Steroids: What’s Suppressed — and What Stays Strong

A clear, reassuring guide for people living with ABPA, CPA, asthma, SAFS, or bronchiectasis

Treatments for aspergillosis-related conditions often involve steroids, and more recently, biologics.
Many patients understandably wonder:

What do these medicines suppress?
Do they affect my ability to fight infection?
Why are biologics considered safer than long-term steroids?
Which parts of my immune system stay strong?

This guide explains the full picture in simple terms.

🧬 1. Understanding Your Immune System: The Three Layers

Your immune system has three major lines of defence.

⭐ A. Barriers — the first line

These stop pathogens entering in the first place:

Skin
Mucus in airways
Cilia sweeping mucus out
Tears, saliva, stomach acid
Healthy bacteria (microbiome)

👉 Biologics do NOT affect barriers.
👉 Steroids can weaken skin and airway lining if used long-term.

⭐ B. Innate immunity — fast responders

These act within minutes or hours.

Key cells:

Neutrophils → main killers of Aspergillus
Macrophages → engulf spores
Dendritic cells → show pathogens to T-cells
NK cells → kill virus-infected cells

Sensors:

Dectin-1 → recognises fungal walls
TLRs
Complement proteins

👉 Biologics do NOT weaken these.
👉 Steroids weaken several key functions, especially neutrophils and macrophages.

⭐ C. Adaptive immunity — targeted, long-term defence

Slower but specialised.

T-cells:

Th1 → fight bacteria/viruses
Th17 → major antifungal fighters
Th2 → allergic pathways (IgE, eosinophils)
Tregs → calm inflammation

B-cells & antibodies:

IgG / IgA / IgM → normal infection defence
IgE → allergy and ABPA pathway

👉 Biologics only suppress Th2/IgE pathways.
👉 Steroids suppress many T-cell and B-cell functions, not just allergy.

🎯 2. What Biologics Suppress (Targeted & Selective)

Biologics used in ABPA and difficult asthma (omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab) only turn down allergic inflammation, not infection-fighting immunity.

🔻 A. They suppress:

IgE
Eosinophils
IL-4 / IL-5 / IL-13
Type-2 allergic inflammation
Mucus hypersecretion (IL-13)
TSLP airway alarm signalling

🛡️ B. They do NOT suppress:

Neutrophils
Macrophages
Th1 immunity
Th17 antifungal pathways
T-cell killing function
Antibiotic/cell-mediated defences
Complement
Dectin-1 fungal recognition

This is why biologics do NOT increase fungal infection risk.

🔥 3. What Oral Steroids Suppress (Broad & Non-Specific)

Oral steroids like prednisolone reduce inflammation everywhere — including places you need for infection defence.

❌ A. They suppress key immune cells

Neutrophils → move slower, kill less effectively
Macrophages → reduced pathogen killing
T-cells → weaker antiviral/antifungal defence
B-cells → reduced antibody production

❌ B. They suppress important cytokines

IL-1, IL-2, IL-6
TNF-α
Interferons
IL-12, IL-23 (Th1/Th17 pathways)

These are essential for fighting viruses, bacteria, and fungi.

❌ C. They weaken antigen presentation

Dendritic cells and macrophages become less effective at “showing” pathogens to T-cells.

❌ D. They weaken barriers

Thinner skin
Thinner airway lining
Slower wound healing

This increases infection risk.

❌ E. They reduce eosinophils and IgE (similar to biologics)

But they do this alongside suppressing many healthy parts of your immune system.

🛡️ 4. What Remains Intact on Each Treatment

✔ On biologics (strongest preserved immunity):

Neutrophil antifungal killing
Macrophage function
Th1 & Th17 immunity
Antibodies (IgG, IgA, IgM)
Complement
Mucus & cilia defences
NK cell antiviral defence
Fever & inflammation responses

⚠️ On steroids (weaker preserved immunity):

Complement
Some antibody production
Basic barrier function (though thinner)

Many infection-fighting cells work less effectively.

🫁 5. Why Biologics Are Safer Long-Term for ABPA/SAFS

Because biologics:

target only a tiny portion of immunity
do not increase fungal growth
do not raise infection risk
reduce inflammation without broad suppression
help avoid long-term steroid complications

Steroids:

increase infection risk
can worsen fungal colonisation
damage lung structure over time
cause weight gain, bone thinning, adrenal issues
must be used short-term only when essential

🌈 6. Summary Table

Immune Feature	Biologics	Steroids
IgE suppression	✔	✔
Eosinophil suppression	✔	✔
Neutrophils	Unaffected	Suppressed
Macrophages	Unaffected	Suppressed
Th1/Th17 antifungal pathways	Unaffected	Suppressed
Viral defence	Unaffected	Suppressed
Barrier integrity	Unaffected	Weakened
Infection risk	No increase	Increased
Long-term safety	High	Low

🌟 7. One-Sentence Takeaway

Biologics turn down the allergic part of immunity (IgE, IL-4, IL-5, IL-13, eosinophils), while steroids suppress many of the infection-fighting parts as well — which is why biologics are much safer long-term.

by GAtherton

❤️ Thinking About Donating Blood After Aspergillosis or Lung Treatment?

A supportive message for people living with ABPA, CPA, SAFS, and related lung conditions

When you live with aspergillosis or a long-term lung condition, you know what it means to go through difficult treatments, long recoveries, and moments of uncertainty.
So when someone says, “Once I’m well, I’d like to donate blood to help others,” it is an incredibly generous and hopeful act.

Many people in our community wonder whether blood donation is possible after lung surgery, long-term inhalers, antifungals, or biologics. The reassuring answer is:

👉 Yes — some aspergillosis patients can donate blood once fully recovered, but it depends on individual treatments and health status.

And even if you can’t donate, the spirit behind the idea is powerful and meaningful.

🌱 1. Recovery comes first — your health is the priority

Whether you’ve had:

ABPA flare-ups
CPA treatment
bronchoscopy
long-term antifungals
biologics
a lobectomy or wedge resection

…the NHS will want you to be:

fully healed
breathing comfortably
stable in your lung condition
free from infection
strong enough to safely donate

For major surgery like a lobectomy, this often means several months of recovery before you can even be reviewed for donation.

This protects your health, not just the receiver’s.

💊 2. Medications commonly used for aspergillosis can affect eligibility

NHS Blood and Transplant will look closely at what you’re taking.

Here’s a simple guide:

Often NOT permitted

Biologics (e.g., mepolizumab, benralizumab, dupilumab)
Long-term immunosuppressants
Regular systemic steroids

May require a delay after stopping

Itraconazole / voriconazole / posaconazole
Recent antibiotic courses
Short steroid bursts

Usually fine

Inhalers
Nebulised saline
Montelukast
Airway clearance treatments
Most pain medicines

Every case is assessed individually — there is no automatic “yes” or “no” for all aspergillosis patients.

🫁 3. Your lung condition does not automatically exclude you

Having ABPA, CPA, bronchiectasis, or SAFS does not automatically prevent blood donation.

What matters is:

your condition is stable
your oxygen levels are good
you are not prone to sudden flare-ups
you feel well and strong

Many people with asthma or mild-to-moderate bronchiectasis still donate safely.

🩸 4. Your blood type is always valuable

Whether you’re a universal donor type (O-negative) or any other type, your blood can help save lives.

Even wanting to donate is something to be proud of — especially after everything you’ve been through.

🌟 5. The intention to donate speaks volumes about your strength

People living with aspergillosis know:

what it means to struggle for breath
how it feels to wait for test results
the exhaustion of flare-ups
the courage needed for surgery
the patience required for long-term treatment

So when someone in this community says:

“If I recover well, I want to donate blood to help someone else.”

…it’s a truly inspiring message of recovery and generosity.

🌈 6. Even if you can’t donate — your kindness still matters

Because of medications or long-term conditions, some people with aspergillosis will be told they can’t donate blood. This is completely normal.

You can still help others by:

encouraging friends or family to donate
sharing your story to raise awareness
supporting patient groups, campaigns, and research
simply being there for someone newly diagnosed

Your contribution to the world is not measured by a needle — it’s measured by your compassion.

❤️ Takeaway message

If you want to donate blood after aspergillosis treatment or lung surgery, that’s a beautiful intention. When you’re fully recovered, the NHS can review your health and medications. Whether you can donate or not, the willingness to help others already makes a real difference.

by GAtherton

🌿 ABPA: Infection, Allergy, Biologics, and What It All Means for You

A calm, supportive guide for patients living with Allergic Bronchopulmonary Aspergillosis (ABPA)

Allergic Bronchopulmonary Aspergillosis (ABPA) can be confusing.
Some people hear “fungus” and think it is a dangerous infection.
Others hear “allergy” and think it has nothing to do with fungi at all.

The truth is somewhere in the middle — and understanding this can make your treatment feel much clearer and less frightening.

This article explains:

Whether ABPA is an infection, an allergy, or both
How the fungus Aspergillus fumigatus fits into the picture
Why biologics help — and whether they allow the fungus to grow
Why your future with ABPA is more hopeful than ever

🌼 1. Is ABPA an infection or an allergic over-reaction?

The simplest explanation is:

ABPA happens when Aspergillus lives in mucus in the airways, and the immune system overreacts. It’s driven by allergy, not by fungal invasion.

In ABPA:

Aspergillus fumigatus sits in mucus, especially in asthma, bronchiectasis or cystic fibrosis
It does not invade or damage lung tissue
The immune system becomes over-sensitised and reacts too strongly

This allergic reaction triggers:

Very high IgE
High eosinophils
Swelling, tightness, wheeze
Thick “stringy” mucus or plugs
Repeated flare-ups that feel like chest infections

The inflammation — not the fungus — is what damages the lungs over time.

🌻 2. If it’s not a typical infection, why treat the fungus?

Even though ABPA is allergic, reducing fungal load can still help.

Here’s why:

Less fungus in mucus → less allergen
Less allergen → less immune reaction
Less reaction → fewer flare-ups, better breathing

This is why some people take antifungals.
But antifungals are not always necessary, especially today with the arrival of biologics.

🌈 3. Do biologics weaken the immune system and let the fungus grow?

No.
This is a very common worry — but the biologics used for ABPA do not suppress the parts of the immune system that keep you safe from fungi.

Biologics such as:

Omalizumab (anti-IgE)
Mepolizumab / Benralizumab (anti-IL-5)
Dupilumab (anti-IL-4/IL-13)
Tezepelumab (anti-TSLP)

target overactive allergic pathways, not antifungal defences.

They do not affect:

Neutrophils
Macrophages
Dectin-1
TLR antifungal pathways
Complement

These are the real fungus-clearing systems — and biologics leave them intact.

🍃 4. Do biologics actually help clear fungus? Surprisingly, sometimes yes.

Many patients on biologics show:

Fewer mucus plugs
Better airflow
Fewer positive sputum cultures
Reduced symptoms
Lower exacerbation rates
Less need for steroids or antifungals

When mucus plugs shrink, fungus loses its hiding place.
Your natural defences can finally clear it.

So biologics do not encourage growth — they may even help reduce fungal load.

🌺 5. Why are outcomes improving so much?

ABPA used to be a condition dominated by:

frequent flare-ups
repeated steroids
fear of lung damage
long periods of being unwell

Today, with biologics:

far fewer flare-ups
easier breathing
more stable lung function
much less steroid use
better quality of life
higher confidence and control

For many patients, biologics are transforming ABPA from a cycle of crises into a more manageable long-term condition.

🌼 6. Key reassurance

If you remember only one sentence, let it be this:

Biologics calm the allergic response that causes ABPA, without weakening your natural ability to clear fungus — and many patients do better than ever on them.

🌟 7. Moving forward with confidence

ABPA is complex, but it is treatable, manageable, and increasingly well-understood.
You are not dealing with a dangerous lung infection — you are dealing with an over-active immune response that modern treatments can control.

With the right support, airway clearance, the best inhalers, and (where needed) biologics or antifungals, most people:

stabilise
breathe more easily
reduce flare-ups
protect their lungs
live full, active lives

You’re not alone — and the future for ABPA care has never looked brighter.

by GAtherton

⭐ How to Avoid Being Fooled by Misleading Products, Private Tests and Health Claims

A practical, evidence-based guide for people living with aspergillosis, asthma, bronchiectasis and COPD

People with long-term lung conditions are often targeted by persuasive marketing, “health influencers”, alternative practitioners, and private test companies.
These services frequently exploit fear, frustration, and the very understandable desire for answers.

This expanded guide explains why certain products look scientific, why most are biologically impossible, and how you can protect yourself from being misled or spending money on things that cannot help your condition.

This is about empowerment — never about blaming patients.

🧩 1. Why misleading products look convincing

Companies deliberately use wording and imagery that trigger trust:

lab coats
microscopes
graphs and biological diagrams
words like “antifungal”, “immune”, “toxins”, “wellness”, “clinical strength”

These features make a product appear evidence-based — but appearance is not evidence.

Many claims contain a grain of truth, e.g.:

“Tea tree oil kills fungus in the lab”
“Silver has antimicrobial properties”
“This herbal extract reduces inflammation in laboratory tests”

But the missing information is the critical part:

⭐ The lab conditions have nothing to do with the human body.

To “kill fungus in a dish”, companies use concentrations that:

would be toxic in humans
cannot reach the lung tissue
would be broken down in the gut or bloodstream
do not survive into the airways

Companies rely on the fact that most customers don’t know this.

🧬 2. “Plausibility comes before testing” — the rule companies hope you don’t know

Scientists follow a simple chain:

1️⃣ Is it plausible?
Can the substance reach the lung?
Does the pathway make sense?

2️⃣ If yes — test it.
If not — don’t.

Products sold online almost always fail at Step 1.

Examples:

Turmeric supplements

Even at huge oral doses, only a tiny amount enters the bloodstream — nowhere near the lung in meaningful levels.

Oregano oil

Kills fungi on metal plates in labs — but the amount needed inside the lung would be toxic.

Silver products

Irritate the lungs and accumulate in tissues — highly implausible as therapy.

Essential oils

Break down long before reaching the airways in meaningful amounts.

Herbal antifungals

Often metabolised by the gut and liver — never reach airways at therapeutic levels.

This is why clinical trials don’t happen —
not because no one has tried,
but because there’s no scientific reason to bother.

🛍️ 3. How companies use “allowed” claims to sound medical

Because these products are not classed as medicines, they must not claim to “treat disease”.
So companies use vague, legally safe wording:

“Supports immunity”
“Maintains wellness”
“Promotes respiratory health”
“Contains antifungal botanicals”
“Helps with mould exposure”
“Advanced detox science”

All of these sound medical but say nothing measurable.

Example:

A supplement cannot say:

“Improves aspergillosis symptoms”

But it can say:

“Supports healthy immune response”

This tricks the viewer into mentally connecting the dots without the company making any illegal claims.

🧊 4. Air filters — the rare partial exception

Air purifiers can help some people, because they reduce:

dust
pollen
irritants
pet dander
airborne particulate matter

These changes may ease coughing or wheezing in sensitive people.

BUT…

most devices sold online are far too weak.

A purifier needs:

True HEPA H13 filter (not “HEPA-type”)
CADR 250–350+ for most rooms
Strong fan to turn over room air 4–5 times per hour

Without these, a purifier is just an expensive fan.

What they cannot do:

cure aspergillosis
remove Aspergillus from the lungs
prevent exposure
substitute for ventilation
fix damp or mould in walls

They improve comfort, not disease.

👩‍⚕️ 5. Why alternative practitioners are so persuasive

Alternative practitioners often:

speak with confidence
promise personalised care
provide long consultations
listen sympathetically
use scientific-sounding language
offer simple explanations for complex symptoms

Their tests and treatments look legitimate, but the problems include:

❌ No training in lung disease

❌ Misunderstanding of immunology

❌ Misuse of lab dish studies

❌ Incorrect interpretation of “toxins”

❌ Selling supplements with no evidence

❌ Recommending dangerous inhaled substances (e.g., oils, peroxide)

❌ Relying on anecdotes, not data

Even well-meaning practitioners can unintentionally cause:

lung irritation
drug interactions
adrenal effects
delays in proper NHS treatment
unnecessary fear

🧪 6. Private test companies — why their results look real but mean nothing

Common private tests include:

mycotoxin urine tests
“mould illness panels”
detox pathway testing
food IgG tests
fungal metabolite tests
heavy metal hair analysis
“immune balance” panels
testosterone finger-prick kits

These results are presented with:

charts
colour-coded ranges
expert-sounding commentary

But the key issue is:

⭐ The reference ranges are invented by the company.

Often “high” simply means:

“higher than the average of people who bought this test”

Not:

higher than healthy people
higher than unwell people
linked to disease

GPs and consultants cannot act on these results because they are not medically interpretable.

👨‍⚕️ 7. Testosterone tests — a perfect illustration of misleading health screening

Companies advertise:

“Tired? Low mood? Low motivation?”
“Check your testosterone at home”
“Feel younger again”

They use US-style messaging that implies easy treatment.

But in the UK, testosterone treatment requires:

symptoms consistent with hypogonadism
two morning venous blood tests
validated hospital labs
endocrine specialist interpretation
ruling out multiple other causes
testosterone levels fall slowly as part of ageing - it is normal

Finger-prick tests do not meet NHS criteria,
so patients end up:

anxious
misinformed
sold supplements
not eligible for NHS treatment

This perfectly mirrors the broader pattern of private testing.

🔍 8. The “curiosity gap”: why people buy tests that GPs won’t order

Patients understandably feel:

frustrated
curious
confused
not listened to
desperate for answers

When a GP says “That test won’t help,” it can feel like:

rejection
dismissal
obstruction

But the reality is:

⭐ GPs are following evidence-based pathways to protect you.

Most private tests:

do not answer a clinical question
have false positives
trigger unnecessary follow-up scans
cause anxiety
cannot be interpreted
do not influence treatment

Private companies exploit:

curiosity
frustration
the desire for answers
the emotional gap left by long waits or unexplained symptoms

But a meaningless test result is worse than no test at all.

🧾 9. Real-world examples: 15 common traps to avoid

1. Mould settle plates

All rooms grow mould on plates — totally meaningless for health.

2. IgG food sensitivity tests

Measure normal immune exposure, not allergies.

3. Finger-prick vitamin tests

Often inaccurate and label normal levels as “borderline”.

4. Lung detox drinks

Nothing you drink detoxes the lungs.

5. Hydrogen peroxide / silver nebulisers

Dangerous. Irritate lungs. Risk chemical burns and pneumonitis.

6. Essential oil diffusers marketed as “antifungal”

Irritate airways; no delivery to lung tissue.

7. Mycotoxin detox programmes

Based on non-diagnoses; push expensive supplements.

8. Immune-boosting products

No supplement boosts immunity in a useful way for aspergillosis.

9. “Black mould blood tests”

No such test exists; ranges are invented.

10. Ozone machines and air ionisers

Harmful to lungs; zero evidence.

11. Anti-mould paint additives

Mask damp; do not impact indoor fungal counts long term.

12. Red-light therapy devices

Cannot penetrate tissue; no lung benefit.

13. Detox foot patches

Turn brown from sweat; total scam.

14. Anti-mould laundry boosters

Irrelevant to aspergillus exposure.

15. Humidifiers sold for “lung support”

Raise humidity → increase mould risk.

🛡️ 10. The Anti-Fooling Checklist

Before you buy anything, ask:

✔ Has this been tested in people with aspergillosis?

✔ Can it physically reach the lungs?

✔ Does NHS medicine recognise or use it?

✔ Are the claims vague? (“supports immunity”)

✔ Are the reference ranges medically valid?

✔ Would my consultant recommend this?

✔ Is this a simple answer to a complex condition?

If any answer is no, it’s a red flag.

⭐ 11. Golden rule

If a treatment or test genuinely helped aspergillosis, your consultant would already be using it —
not influencers, Amazon sellers, or unregulated US labs.

🌟 12. Final message: It’s not foolishness — it’s human

You are not being “tricked” because you’re naïve.
These products are engineered to be emotionally irresistible.
People with chronic illness are targeted because they are thoughtful, curious, and trying hard to get better.

If you are ever unsure about a product or test:

ask NAC/CARES
ask your specialist
or bring it to your next appointment

You deserve real answers — not false hope.

by GAtherton